Does AI touch your quality system?
The EU AI Act's next enforcement phase is in effect, FDA has published its expectations for AI model credibility, and AI features are already shipping inside your eQMS, LIMS, and document workflows. Most quality teams cannot yet say where their exposure sits. I help you find out — in two weeks, with a documented method.
AI Readiness Gap Assessment for GxP Quality Systems
A two-week, fixed-scope assessment for pharma, biologics, and medical device quality organizations. No open-ended consulting retainer — a defined method, a defined deliverable, a defined price.
Abel Salgado
Ten-plus years implementing the quality systems that keep regulated products moving and audits clean — Veeva Vault and Oracle Cloud eQMS environments across pharma, biologics, and medical device. Document control, CAPA and deviation management, CSV/CSA, and CMO/CDMO oversight under 21 CFR Parts 11, 210/211, 820, and EU Annex 11.
Most AI experts can't tell you what enforcement means for a validated system. Most QA teams can't tell you where AI has already crept into theirs. I work in the overlap — bringing the same validation rigor to AI that I'd bring to any GxP system.
AIGP CANDIDATE · EXAM AUG 2026
BILINGUAL ENGLISH / SPANISH · SAN DIEGO · ON-SITE OR REMOTE
Book a 20-minute exposure review
Bring a list of your quality systems. In twenty minutes you'll have a first read on where AI likely already touches them and whether a full assessment is worth your budget. If it isn't, I'll tell you that too.
Pick a time Prefer email? abelsalgado@gmail.com